RT Book, Section
A1 Bhatti, Saad A.
A1 Braich, Karen
A1 Lapsia, Vijay
A2 Go, Ronaldo Collo
SR Print(0)
ID 1160187653
T1 Acute Kidney Injury and Renal Replacement Therapy
T2 Critical Care Examination and Board Review
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9781259834356
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1160187653
RD 2024/10/07
AB The  incidence  of  dialysis-requiring  acute  kidney  injury  (AKI-D)  has  increased  in  the  past  decade  in  the  United  States.  From  2000  to  2009,  there  were  1.09  million  hospitalizations  (95%  confidence  interval  [CI],  1.04–1.15  million)  with  AKI-D  in  the  United  States.  From  2007  to  2009,  the  population  incidence  of  AKI-D  increased  by  11%  per  year  (95%  CI,  1.07–1.16;  P  <  0.001).1  Hospitalized  patients  with  AKI-D  were  older  than  their  counterparts  who  did  not  have  AKI-D  (63.4  vs  47.6  years),  were  more  likely  to  be  male  (57.3%  vs  41.1%),  to  be  black  (15.6%  vs  10.2%),  to  have  sepsis  (27.7%  vs  2.6%),  to  have  heart  failure  (6.2%  vs  2.7%),  and  to  undergo  cardiac  catheterization  (5.2%  vs  4.4%)  and  mechanical  ventilation  (29.9%  vs  2.4%).1  The  temporal  trend  in  the  6  diagnoses—septicemia,  hypertension,  respiratory  failure,  coagulation/hemorrhagic  disorders,  shock,  and  liver  disease—sufficiently  and  fully  accounted  for  the  temporal  trend  in  AKI-D.2  This  chapter  will  discuss  the  diagnosis  of  acute  kidney  injury  and  types  of  renal  replacement  therapy.